Curexo CUVIS-joint cumulative surgeries and United States clearance

Curexo's CUVIS-joint has about 43,000 cumulative surgeries across nine or more countries, and received United States FDA approval in March 2026, roughly nine months after a July 2025 filing. Press reporting of company figures.

Supporting location Article body, cumulative case count and FDA timeline

No current answer cites this record.